Methods and compositions of PI-3 kinase inhibitors for treating fibrosis

Details for Australian Patent Application No. 2010234360 (hide)

Owner Oncothyreon, Incorporated

Inventors Hardie, William; Kirkman, Robert

Agent Spruson & Ferguson

Pub. Number AU-A-2010234360

PCT Pub. Number WO2010/118250

Priority 61/235,740 21.08.09 US; 61/167,905 09.04.09 US

Filing date 8 April 2010

Wipo publication date 14 October 2010

International Classifications

A61K 31/35 (2006.01) - having six-membered rings with one oxygen as the only ring hetero atom

A61K 31/37 (2006.01)

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

Event Publications

29 September 2011 PCT application entered the National Phase

  PCT publication WO2010/118250 Priority application(s): WO2010/118250

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010234362-Alphavirus replicon particles expressing TRP2

2010234359-Retention assembly for cutting bit